BioSigbiomedical signal processing (open source software library)
BioSigBiometric Signature
BioSigBiometrics and Electronic Signatures (working group)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
BioSig Technologies is developing a proprietary biomedical signal processing platform designed to address an unmet technology need in the USD4.6bn electrophysiology marketplace.
Biosig, the Supreme Court set a new and stronger standard for the degree of ambiguity that is acceptable in a valid claim.
Alois Shloegl; we kindly appreciate his work on including data format of Galileo Planet 200 EEG device into BIOSIG [3], which helped us very much.
BioSig Technologies announced that it will be receiving 15 units of its PURE EP System from its manufacturer in preparation for the Company's limited market release later this month.
A RZ6 workstation and BioSig software (Tucker Davis Technologies Inc.) were used for the stimulus generation, presentation, ABR acquisition, and data management.
Currently, Fischer is the chief executive officer and a director of Vivus, Inc, a member of the board of directors of BioSig Technologies, Inc as well as an advisor to MedHab.
BioSig Technologies announced that the Company has issued their June 2019 Shareholder Letter, highlighting patient cases using PURE EP System at three different medical centers, strengthening of patent portfolio and publication strategy, inclusion on the Russell 3000 Index, and other milestones moving toward commercialization.
(128) The claims specified electrodes having a "spaced relationship with each other." (129) Despite that generic phrase, the court held that Biosig's claims were sufficiently definite under the reasonable-certainty standard.
Biosig wins victory from Federal Circuit over patent dispute
What to do if someone is infringing on your patent Biosig wins victory from Federal Circuit over patent dispute _____________________________________________________________________________________________
Biosig Instruments, Inc., (4) but not by addressing interpretation of patent claims (known as claim construction).